ESPE Abstracts

Background: Recombinant human growth hormone (rhGH) therapy is a long-term injection treatment that can be burdened by poor adherence. Although adherence rates are usually good in childhood, children and adolescents can be particularly stressed by daily injections, resulting in a low quality of life (QoL).Objectives: To assess the degree of adherence and stress related to daily rhGH treatment based on data reported by pa...